Endometrial Abnormality in Women With Polycystic Ovary Syndrome

被引：1
作者：
Kewei Shang
Xiao Jia
Jie Qiao
Jihong Kang
Youfei Guan
机构：
[1] Peking University Health Science Center,Department of Physiology and Pathophysiology
[2] Peking University Third Hospital,Department of Obstetrics and Gynecology
来源：
Reproductive Sciences | 2012年 / 19卷
关键词：
polycystic ovary syndrome; infertility; endometrial abnormality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy associated with infertility and metabolic disorder in women of reproductive age. Although the clinical and biochemical features are heterogeneous with individuals, the most widely accepted clinical characteristics of PCOS are oligo- or anovulation combined with hyperandrogenism. With the higher rate of implantation failure after induction of ovulation or higher risk of spontaneous miscarriage after pregnancy, the reduced fertility is apparently attributed not only to anovulation but also to endometrial dysfunction in patients with PCOS. Here we review the features of the endometrial abnormalities in women with PCOS. The ability to improve the endometrial functions is of potential therapeutic targets to increase reproductive outcome of women with PCOS.
引用
收藏
页码：674 / 683
页数：9
相关论文
共 356 条
[81]  
Giudice LC(1996)Control of transcription by steroid hormones Ann N Y Acad Sci 784 93-123
[82]  
Pillay OC(1994)Androgen regulation of the insulin-like growth factor-I and the estrogen receptor in rat uterus and liver J Steroid Biochem Mol Biol 51 57-66
[83]  
Te Fong LF(2000)Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa) J Steroid Biochem Mol Biol 74 235-241
[84]  
Crow JC(1994)Androgens induce prolactin production by human endometrial stromal cells in vitro J Clin Endocrinol Metab 78 165-168
[85]  
Iatrakis G(1996)Maintenance of decidual cell reaction by androgens in the mouse Biol Reprod 55 519-524
[86]  
Tsionis C(1997)Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis Endocr Rev 18 774-800
[87]  
Adonakis G(1994)Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy Metabolism 43 647-654
[88]  
Shah B(2007)The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome Am J Obstet Gynecol 196 402-50
[89]  
Parnell L(2009)Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review Endocr Rev 30 1-4096
[90]  
Milla S(2004)Evidence for the presence of glucose transporter 4 in the endometrium and its regulation in polycystic ovary syndrome patients J Clin Endocrinol Metab 89 4089-374
45678910111213